TT Capital Management’s Pfizer PFE Stock Holding History

TT Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$693K	Sell	24,300 -3,555	-13%	-$94.6K	0.51%	43
2026 Q2	$671K	Sell	27,855 -500	-2%	-$13.1K	0.52%	42
2026 Q1	$796K	Sell	28,355 -1,150	-4%	-$30.6K	0.66%	31
2025 Q4	$735K	Sell	29,505 -905	-3%	-$22.8K	0.59%	32
2025 Q3	$775K	Sell	30,410 -3,050	-9%	-$75.3K	0.59%	32
2025 Q2	$811K	Buy	33,460 +922	+3%	+$21.5K	0.66%	29
2025 Q1	$825K	Buy	32,538 +5,725	+21%	+$150K	0.69%	26
2024 Q4	$710K	Buy	+26,813	New	+$727K	0.57%	33

Other funds holding PFE

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

TT Capital Management's PFE Position: Q3 2026 in Review

TT Capital Management reduced its Pfizer (PFE) stake by 13% in Q3 2026, selling an estimated $94.6K and leaving 24,300 shares worth $693K. The position accounts for 0.51% of the portfolio, ranked #43.

TT Capital Management first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. The position peaked at $825K in Q1 2025. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

TT Capital Management held 24,300 shares of Pfizer worth $693K as of Q3 2026.
TT Capital Management sold 3,555 Pfizer shares in Q3 2026, an estimated $94.6K.
Pfizer made up 0.51% of TT Capital Management's portfolio in Q3 2026, its #43 holding.
TT Capital Management first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
TT Capital Management's Pfizer position peaked at $825K in Q1 2025.
1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on TT Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.